Reflecting the inflammatory nature of the disease, pathology is dependent on inflammatory cytokines and is attenuated by IL-6 deficiency (106), IFNγ deficiency (111), IFNAR-1 deficiency (118), or treatment with neutralizing anti-BAFF antibody (111). The gene discussed is IFNAR1; the disease is hyperinsulinemic hypoglycemia, familial, 4.